1. Lee HJ, Kim J, Chang SA, Kim YJ, Kim HK, Lee SC. Major clinical issues in hypertrophic cardiomyopathy. Korean Circ J. 2022; 52:563–575. PMID:
35929051.
2. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001; 104:1076–1082. PMID:
11524405.
3. Cho JY, Cho DH, Youn JC, et al. Korean Society of Heart Failure guidelines for the management of heart failure: definition and diagnosis. Korean Circ J. 2023; 53:195–216. PMID:
37161680.
4. Jung Y, Kim J, Jang H, Kim G, Kwon YW. Strategy of patient-specific therapeutics in cardiovascular disease through single-cell RNA sequencing. Korean Circ J. 2023; 53:1–16. PMID:
36627736.
5. Raghow R. An ‘Omics’ perspective on cardiomyopathies and heart failure. Trends Mol Med. 2016; 22:813–827. PMID:
27499035.
6. Michelhaugh SA, Januzzi JL Jr. Finding a needle in a haystack: proteomics in heart failure. JACC Basic Transl Sci. 2020; 5:1043–1053. PMID:
33145466.
7. Dupree EJ, Jayathirtha M, Yorkey H, Mihasan M, Petre BA, Darie CC. A critical review of bottom-up proteomics: the good, the bad, and the future of this field. Proteomes. 2020; 8:14. PMID:
32640657.
8. Shimada YJ, Raita Y, Liang LW, et al. Comprehensive proteomics profiling reveals circulating biomarkers of hypertrophic cardiomyopathy. Circ Heart Fail. 2021; 14:e007849. PMID:
34192899.
9. Shimada YJ, Raita Y, Liang LW, et al. Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling. Circ Genom Precis Med. 2022; 15:e003546. PMID:
36252118.
10. Tayal U, Verdonschot JA, Hazebroek MR, et al. Precision phenotyping of dilated cardiomyopathy using multidimensional data. J Am Coll Cardiol. 2022; 79:2219–2232. PMID:
35654493.
11. Lee S, Jang DG, Kyoung YJ, et al. Proteome-wide characterization and pathophysiology correlation in non-ischemic cardiomyopathies. Korean Circ J. 2024; 54:468–481. PMID:
38956938.